2,4-Bis(trichloromethyl)-1,3,5-triazine | 3599-74-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 2,4-Bis(trichloromethyl)-1,3,5-triazine
• CAS: 3599-74-4
• 化学式: C₅HCl₆N₃
• 分子量: 315.8
• InChiKey: QZZJTWAHFMBFSX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  38.7
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION<br/>[FR] NOUVEAUX PHOTO-INITIATEURS EN TRIAZINE ET LEUR PRÉPARATION
  申请人：COVESTRO DEUTSCHLAND AG

  公开号：WO2016207161A1

  公开（公告）日：2016-12-29

  The present invention relates to new triazine photoinitiators, a new process for their preparation, and a photopolymer composition comprising a photopolymerizable component and the new triazine photoinitiators. Further aspects of the present invention are a photopolymer comprising said photopolymer composition, a holographic medium which comprises such a photopolymer, a hologram comprising the holographic medium, and a device such a display, chip card, security document, bank note and / or holographic optical element comprising said hologram.

  本发明涉及新的三嗪光引发剂，其制备的新工艺，以及包括光聚合组分和新的三嗪光引发剂的光聚合物组合物。本发明的进一步方面包括包括所述光聚合物组合物的光聚合物，包括这样一种光聚合物的全息介质，包括全息介质的全息图，以及包括所述全息图的显示器、芯片卡、安全文件、纸币和/或全息光学元件的装置。
• Polymerizable composition and compound therefor
  申请人：Fuji Photo Film Co., Ltd.

  公开号：EP1466893A1

  公开（公告）日：2004-10-13

  To provide a polymerizable composition suitable for a lithographic printing plate precursor which can satisfy the requirements of high sensitivity, excellent storage stability and long press life and enables direct platemaking from digital data from computer, etc. when recording is conducted a solid laser or semiconductor laser emitting ultraviolet ray, visible light or infrared ray and a compound therefore, the present invention relates to a photoradical polymerizable composition comprising a polyfunctional crosslinking agent having a specific structure represented by formula (I) or (II) defined in the specification.

  提供一种适用于光刻印刷版前体的可聚合组合物，该组合物能够满足高灵敏度、优异的储存稳定性和长压印寿命的要求，并且在进行记录时可以直接从计算机等数字数据中制版，所述记录是通过固体激光或半导体激光发射紫外线、可见光或红外线以及一种化合物进行的。因此，本发明涉及一种包括具有特定结构的多功能交联剂的光自由基聚合组合物，所述结构由规范中定义的式(I)或(II)表示。
• [EN] TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS<br/>[FR] COMPOSÉS DE TRIAZINE ET LEURS COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DU PALUDISME ET DE CHIMIOPROPHYLAXIE
  申请人：US OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF THE WALTER REED ARMY INST OF

  公开号：WO2014159993A1

  公开（公告）日：2014-10-02

  Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.

  本文披露了三嗪化合物及其制备和使用方法，用于治疗疟疾、提供化学预防和/或治疗或抑制一种或多种疟原虫感染。
• [EN] SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS<br/>[FR] DÉRIVÉS DE SULFONIUM ET LEUR UTILISATION EN TANT QU'ACIDES LATENTS
  申请人：BASF SE

  公开号：WO2010046240A1

  公开（公告）日：2010-04-29

  Compounds of the formula (I), wherein Ar1 is for example phenylene or biphenylene both unsubstituted or substituted; Ar2 and Ar3 are for example independently of each other phenyl, naphthyl, biphenylylyl or heteroaryl, all optionally substituted; or Ar1 and Ar2 for example together with a direct bond, O, S or (CO), form a fused ring system; R is for example hydrogen, C3-C30cycloalkyl or C1-C18alkyl; and R1, R2 and R3 independently of each other are for example C1-C10haloalkyl; are effective photoacid generators (PAG).

  化合物的公式（I），其中Ar1例如是未取代或取代的苯基或联苯基; Ar2和Ar3例如是独立的苯基，萘基，联苯基或杂环基，均可选取代; 或者例如Ar1和Ar2与直接键，O，S或（CO）一起形成融合的环系统; R例如是氢，C3-C30环烷基或C1-C18烷基; R1，R2和R3独立地例如是C1-C10卤代烷基; 是有效的光酸发生剂（PAG）。
• [EN] SULPHONIUM SALT INITIATORS<br/>[FR] INITIATEURS À BASE DE SELS DE SULFONIUM
  申请人：CIBA HOLDING INC

  公开号：WO2009047151A1

  公开（公告）日：2009-04-16

  Compounds of the formula (I), wherein X is a single bond, CRaRb O, S, NRC, NCORC, CO, SO or SO2; L, L1, L2, L3, L4, L5, L6, L7 and L8 are for example hydrogen, R1 or COT; T denotes T1 or O-T2; T1 and T2 for example are hydrogen, C1-C20alkyl, C3-C12cycloalkyl, C2-C20alkenyl, C5- C12cycloalkenyl, C6-C14aryl, C3-C12heteroaryl, C1-C20alkyl substituted by one or more D, C2- C20alkyl interrupted by one or more E, C2-C20alkyl substituted by one or more D and inter- rupted by one or more E or Q; R1, R2, R3, R4, Ra, Rb and Rc are T1; D is for example R5, OR5, SR5 or Q1; E is for example O, S, COO or Q2; R5 and R6 for example are hydrogen, C1- C12alkyl or phenyl; Q is for example C6-C12bicycloalkyl, C6-C12bicycloalkenyl or C6- C12tricycloalkyl; Q1 is for example, C6-C14aryl or C3-C12heteroaryl; Q2 is for example C6- C14arylene or C3-C12heteroarylene; Y is an anion; and M is a cation; provided that at least one of L, L1, L2, L3, L4, L5, L6, L7 and L8 is other than hydrogen; and provided that (i) at least one of T1 or T2 is a group Q; or (ii) at least one D is a group Q1; or (iii) at least one E is a group Q2; are suitable as photolatent catalysts.

  化合物的式子（I），其中X是单键，CRaRb O，S，NRC，NCORC，CO，SO或SO2; L，L1，L2，L3，L4，L5，L6，L7和L8例如是氢，R1或COT; T表示T1或O-T2; T1和T2例如是氢，C1-C20烷基，C3-C12环烷基，C2-C20烯基，C5-C12环烯基，C6-C14芳基，C3-C12杂芳基，被一个或多个D取代的C1-C20烷基，被一个或多个E中断的C2-C20烷基，被一个或多个D取代并被一个或多个E或Q中断的C2-C20烷基; R1，R2，R3，R4，Ra，Rb和Rc是T1; D例如是R5，OR5，SR5或Q1; E例如是O，S，COO或Q2; R5和R6例如是氢，C1-C12烷基或苯基; Q例如是C6-C12双环烷基，C6-C12双环烯基或C6-C12三环烷基; Q1例如是C6-C14芳基或C3-C12杂芳基; Q2例如是C6-C14芳撑基或C3-C12杂芳撑基; Y是阴离子; M是阳离子; 前提是L，L1，L2，L3，L4，L5，L6，L7和L8中至少有一个不是氢; 并且前提是（i）至少有一个T1或T2是Q组; 或（ii）至少有一个D是Q1组; 或（iii）至少有一个E是Q2组; 适用于光潜催化剂。